Change search criteria ↓

Search results

200 projects found matching your search criteria:

  1. 51. Mechanisms and therapeutic potential of SGLT2/SGLT1 and NHE-1 inhibition in a rat model of heart failure with preserved …

    Principal investigator: dr hab. Urszula Mackiewicz

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

    Call: OPUS 23, Panel: NZ5

  2. 52. Chemical and surgical castration of sex offenders - effective punishment, therapeutic measure or dehumanizing torture? A…

    Principal investigator: Katarzyna Teresa Jakubczak-Fopke

    Uniwersytet Gdański, Wydział Prawa i Administracji

    Call: PRELUDIUM 21, Panel: HS5

  3. 53. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 21, Panel: NZ7

  4. 54. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud…

    Principal investigator: dr Magdalena Białoń

    Instytut Farmakologii PAN

    Call: PRELUDIUM 21, Panel: NZ7

  5. 55. Targeting of metabolic and transcriptomic cross-talk between leukemic cells and macrophages as a therapeutic strategy in…

    Principal investigator: dr Monika Chomczyk

    Instytut Hematologii i Transfuzjologii

    Call: OPUS 22, Panel: NZ5

  6. 56. Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell the…

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

    Call: PRELUDIUM BIS 3, Panel: NZ5

  7. 57. Targeting UDP-glucose and P2Y14 receptor interaction for therapeutic modulation of inflammatory lung diseases

    Principal investigator: dr Tadeusz Piotr Karcz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  8. 58. Inhibition of protein disulfide isomerases as a strategy for reduction of prothrombotic state in atherosclerosis; therap…

    Principal investigator: dr Kamil Przyborowski

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: SONATA 17, Panel: NZ7

  9. 59. Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.

    Principal investigator: dr hab. Natalia Vydra

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: OPUS 22, Panel: NZ5

  10. 60. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 22, Panel: NZ7

  11. 61. Identification and therapeutic targeting of the mRNA splicing alteration mechanisms driven by gain-of-function TP53 muta…

    Principal investigator: dr Magdalena Oroń

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA 17, Panel: NZ5

  12. 62. Searching for new therapeutic targets in polyglutamine diseases

    Principal investigator: prof. Marta Olejniczak

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 22, Panel: NZ2

  13. 63. P-stereodefined phosphorothioate analogs of morpholino" oligonucleotides (sTMO) as a new model of therapeutic nucleic ac…

    Principal investigator: dr Katarzyna Jastrzębska

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: SONATA 17, Panel: ST4

  14. 64. Non-provitamin A carotenoids as a novel therapeutic strategy in intestinal failure associated liver disease (IFALD)

    Principal investigator: dr hab. Maciej Jan Stawny

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM BIS 3, Panel: NZ7

  15. 65. efFect of nanoscale, three dimensIonal arrangement of proteins on biological and Therapeutic activity (FIT)

    Principal investigator: dr Antonina Naskalska

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: OPUS 22 (LAP), Panel: NZ1

  16. 66. The roles and therapeutic potential of distinct dystrophin and utrophin isoforms in the central and peripheral nervous s…

    Principal investigator: dr hab. Patryk Konieczny

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: OPUS 22, Panel: NZ5

  17. 67. Proline metabolism as a novel therapeutic target for diseases associated with mitochondrial dysfunction.

    Principal investigator: dr Karolina Szczepanowska

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA BIS 11, Panel: NZ3

  18. 68. Investigation of the MLK4 biology in breast cancer and search for new therapeutic strategies using innovative PROTAC com…

    Principal investigator: dr Anna Agnieszka Marusiak

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA BIS 11, Panel: NZ5

  19. 69. Role of Mcpip1 in biliary pathobiology: new potential therapeutic opportunities

    Principal investigator: dr Jerzy Kotlinowski

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: SONATA BIS 11, Panel: NZ5

  20. 70. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an…

    Principal investigator: Szymon Tomczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: NZ5

  21. 71. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent…

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

    Call: PRELUDIUM 20, Panel: NZ7

  22. 72. Assessment of SARS-CoV-2 infection in patients with chronic lymphocytic leukemia depending on indicators of immune disor…

    Principal investigator: prof. Ewelina Pia Grywalska

    Uniwersytet Medyczny w Lublinie

    Call: OPUS 21, Panel: NZ6

  23. 73. Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of …

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: OPUS 21, Panel: NZ7

  24. 74. Investigation of a new therapeutic strategy to lower mutant protein in SCA3 / MJD

    Principal investigator: prof. Maciej Figiel

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 21, Panel: NZ2

  25. 75. Verification of personalized therapeutic strategy based on Integrated Stress Response inhibition for myeloid neoplasms w…

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 21, Panel: NZ5

  26. 76. Psychedelics as Therapeutic Candidates in Neurodegenerative Disorders Treatment– a Study in Spinocerebellar Ataxia Type …

    Principal investigator: dr Urszula Joanna Kozłowska

    Instytut Chemii Bioorganicznej PAN

    Call: SONATINA 5, Panel: NZ4

  27. 77. Spectroelectrochemistry of Alzheimer's disease - a study of a new potential therapeutic molecule

    Principal investigator: dr Magdalena Zofia Wiloch-Szyborska

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: SONATINA 5, Panel: ST4

  28. 78. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 20, Panel: NZ7

  29. 79. Development of tools for the rational design of peptide therapeutics

    Principal investigator: prof. Sebastian Kmiecik

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

    Call: OPUS 20, Panel: NZ2

  30. 80. Polymersomes specifically releasing cGAMP and doxorubicin in tumor hypoxic regions as a new anti-cancer therapeutic stra…

    Principal investigator: dr hab. Ryszard Smolarczyk

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: OPUS 20, Panel: NZ5

  31. 81. Mechanism of splicing of MBNL1 transcript and its implications for potential therapeutic strategies for myotonic dystrop…

    Principal investigator: dr Katarzyna Magdalena Taylor

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: SONATA 16, Panel: NZ3

  32. 82. Vitreous Optical Tomography for objective diagnosis, monitoring and outcome measures of therapeutic interventions for vi…

    Principal investigator: dr Daniel Rumiński

    Uniwersytet Mikołaja Kopernika, Wydział Fizyki, Astronomii i Informatyki Stosowanej

    Call: SONATA 16, Panel: NZ5

  33. 83. Toxic RNA with expanded trinucleotide repeats: pathomechanism and therapeutic targets of neurological diseases

    Principal investigator: prof. Krzysztof Sobczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: MAESTRO 12, Panel: NZ3

  34. 84. The significance of circadian rhythm in urinary bladder cancer: deregulation of circadian genes as a putative therapeuti…

    Principal investigator: prof. Edyta Wiesława Reszka

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 19, Panel: NZ5

  35. 85. DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

    Principal investigator: prof. Tomasz Adam Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 19, Panel: NZ7

  36. 86. Screening for new therapeutic targets in inherited retinal diseases based on protein-protein interactions analysis

    Principal investigator: dr Xiaonan Liu

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: POLS, Panel: NZ4

  37. 87. Novel L-asparaginases as potential therapeutic agents and antimicrobial targets: structural and functional studies of en…

    Principal investigator: prof. Mariusz Jaskólski

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 19, Panel: NZ1

  38. 88. Understanding of the mesenchymal stem cells (MSCs)-mediated immune suppression mechanism in the neutrophilic experimenta…

    Principal investigator: dr Marlena Tynecka

    Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim

    Call: PRELUDIUM 19, Panel: NZ5

  39. 89. Assessment of therapeutic value and usefulness of new generation antibiotics and their metabolites as resistance markers…

    Principal investigator: Katarzyna Joanna Pauter-Iwicka

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

    Call: PRELUDIUM 19, Panel: ST4

  40. 90. Improving therapeutic efficacy of anti-CD20 antibodies in precursor B-cell acute lymphoblastic leukemia

    Principal investigator: dr Małgorzata Firczuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 18, Panel: NZ5

  41. 91. The influence of EGFRvIII structure and its cellular distribution heterogeneity on designing new therapeutic and diagnos…

    Principal investigator: prof. Piotr Rieske

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 18, Panel: NZ3

  42. 92. Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic …

    Principal investigator: dr hab. Katarzyna Zofia Kuter-Nowak

    Instytut Farmakologii PAN

    Call: OPUS 18, Panel: NZ7

  43. 93. Exploring influence of inorganic cell microenvironment on NO signalling deregulation in age-related disorders. From mole…

    Principal investigator: prof. Grażyna Jolanta Stochel

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 18, Panel: ST4

  44. 94. The 'omics' of renal cancer nucleolus: towards identification of new cancer markers and therapeutic targets.

    Principal investigator: prof. Agnieszka Piekiełko-Witkowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO, Szkoła Nauk Medycznych

    Call: OPUS 18, Panel: NZ5

  45. 95. Therapeutic application of temporin derivatives in infectious diseases caused by intracellular pathogens.

    Principal investigator: dr Anna Golda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: SONATA 15, Panel: NZ6

  46. 96. Predicting microbiome changes over time and upon perturbation: applications of machine learning to microbiome research a…

    Principal investigator: dr Tomasz Piotr Kościółek

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: SONATA 15, Panel: NZ2

  47. 97. Testing of cation carrier derivatives as prospective therapeutic agents for the treatment of B-cell-derived malignancies…

    Principal investigator: dr Beata Pyrzyńska

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 18, Panel: NZ5

  48. 98. Exploring the role and therapeutic potential of sex hormone binding globulin (SHBG) in the course of insulin resistance,…

    Principal investigator: prof. Krzysztof Mariusz Marycz

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

    Call: OPUS 18, Panel: NZ7

  49. 99. Gankyrin protein as a new potential therapeutic target in multiple myeloma

    Principal investigator: dr hab. Irena Misiewicz-Krzemińska

    Instytut Hematologii i Transfuzjologii

    Call: OPUS 18, Panel: NZ5

  50. 100. Curcuminoid-polyphenol conjugates as potential therapeutics for urinary system cancer treatment

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: OPUS 18, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski